Major Depressive Disorder

During Kidney Week, Christine Liu, MD, discusses some of the issues geriatric patients face.

Despite a higher genetic risk, investigators link physical activity with decreased odds for developing depression.

A new meta-analysis of more than 31 randomized trials found fish oil supplements—specifically omega-3, alpha-linolenic acid, and total polyunsaturated fats—had little to no impact on the treatment or prevention of depression or anxiety symptoms.

How can clinicians and policy makers collaborate to improve the standing of mental health in the US?

A discussion with a director from the American Public Health Association on what drives the increasing burden of mental illness in the US.

How physicians in a shrinking field have taken on a greater burden of leadership roles in patient care.

How does psychiatry access differ among patients, and how should it become individualized?

With ARBs linked to a higher risk of suicide, investigators suggest treating diseases like hypertension, chronic kidney disease, heart failure, and diabetes with ACEIs instead.

While depression does not impact functional recovery much following discharge, both dementia and delirium could affect a geriatric patient’s functional status.

Investigators suggest an upgrade to the existing categorical frameworks for diagnosing mental illnesses, such as obsessive-compulsive disorder and generalized anxiety disorder.

In a new meta-analyses, investigators find a lack of evidence showing the links between antidepressants and adverse health risks.

Investigators deem phase 2 study using pimavanserin to treat major depressive disorder a success.

Investigators find zolpidem effectively reduces suicidal ideation, particularly for patients suffering from severe insomnia symptoms.

While there are many options to treat depression, a balance of therapy and medication is often seen as the best method.

Bipolar depression can be difficult to treat and is often misdiagnosed.

Despite being commonly prescribed as an antidepressant, investigators find sertraline more effective at alleviating anxiety symptoms.

A new study shows that approximately one-quarter of adults aged 18-34 years old with a medical condition have used marijuna in the past month.

A clinical discussion on the underlooked, undertreated, and underperforming facets of a public health crisis.

Acadia Pharmaceuticals has announced positive findings for time to psychosis relapse in dementia patients, which resulted in the trial's early end.

Recent research advances have associated the gut's health to overall patient health. What do we know now?

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.